https://www.selleckchem.com/pr....oducts/terephthalic-
validation of the whole treatment process is the next step in the goal to achieve both a non-invasive and a personalized proton therapy treatment. The feasibility and suitability of a 3D MRI-based treatment planning approach have been successfully tested on a cohort of eight patients diagnosed with UM. Moreover, a gaze-angle trade-off dose optimization with respect to OARs sparing has been developed. Further validation of the whole treatment process is the next step in the goal to achieve both a non-invasive and a personalized
Like
Comment
Share
